Last update 04 Nov 2024
Keyi International Trade (Shanghai) Co., Ltd.

Keyi International Trade (Shanghai) Co., Ltd.

Private Company|
2006|
Shanghai Shi, China
|
www.cetaphil.com.cn

Overview

Tags

Skin and Musculoskeletal Diseases
Toxin

Disease domain score
A glimpse into the focused therapeutic areas
no Data
No Data
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Top 5 Drug TypeCount
Toxin1
Top 5 TargetCount
SNAP25(Synaptosomal-associated protein 25)1

Related

1
Drugs associated with Keyi International Trade (Shanghai) Co., Ltd.
Botulinum toxin A (Q-Med)
Target
SNAP25
Mechanism
SNAP25 inhibitors
Active Org.
Keyi International Trade (Shanghai) Co., Ltd.Keyi International Trade (Shanghai) Co., Ltd. [+3]
Originator Org.
Q-Med ABQ-Med AB
Active Indication
Glabellar frown lines
Inactive Indication
Facial wrinkles [+1]
Drug Highest PhaseNDA/BLA
First Approval Ctry. / Loc.-
First Approval Date-
1
Clinical Trials associated with Keyi International Trade (Shanghai) Co., Ltd.
CTR20221517 / CompletedPhase 3
一项评价QM1114-DP治疗中国受试者中度至重度眉间纹的有效性和安全性的多中心、随机、双盲、阳性对照（BOTOX®）和安慰剂对照研究
[Translation] A multicenter, randomized, double-blind, active-controlled (BOTOX®) and placebo-controlled study to evaluate the efficacy and safety of QM1114-DP in the treatment of moderate to severe glabellar lines in Chinese subjects
100 Clinical Results associated with Keyi International Trade (Shanghai) Co., Ltd.
Login to view more data
0 Patents (Medical) associated with Keyi International Trade (Shanghai) Co., Ltd.
Login to view more data
100 Deals associated with Keyi International Trade (Shanghai) Co., Ltd.
Login to view more data
100 Translational Medicine associated with Keyi International Trade (Shanghai) Co., Ltd.
Login to view more data

Corporation Tree

Boost your research with our corporation tree data.
login
or
view full example data
Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 06 Nov 2024

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Phase 3
1
Login to view more data

Current Projects

Drug(Targets)IndicationsGlobal Highest Phase
Botulinum toxin A (Q-Med)
 ( SNAP25 )		Facial wrinkles
More
Pending
Login to view more data

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Profit

Explore the financial positions of over 360K organizations with Synapse.
login
or
view full example data
Explore the financial positions of over 360K organizations with Synapse.

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.
login
or
view full example data
Access more than 2 million grant and funding information to elevate your research journey.

Investment

Gain insights on the latest company investments from start-ups to established corporations.
login
or
view full example data
Gain insights on the latest company investments from start-ups to established corporations.

Financing

Unearth financing trends to validate and advance investment opportunities.
login
or
view full example data
Unearth financing trends to validate and advance investment opportunities.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free